Aspirin-exacerbated respiratory disease: Update on medical management
Aspirin-exacerbated respiratory disease (AERD) is frequently diagnosed in patients with severe type 2 airway inflammation presenting with nasal polyps and severe asthma. It has been associated with a recalcitrant course with high medical and surgical requirements. The advent of recent biological and...
Guardado en:
Autores principales: | Andrew A. White, Katharine Woessner, Ronald Simon |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
KeAi Communications Co., Ltd.
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/73ca00d87fff4b348cd6858680fce3b7 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The importance of timely diagnosis of aspirin-exacerbated respiratory disease for patient health and safety
por: Kathleen Buchheit, et al.
Publicado: (2020) -
Olfactory outcomes in the management of aspirin exacerbated respiratory disease related chronic rhinosinusitis
por: Daniel B. Spielman, et al.
Publicado: (2020) -
Systematic review of outcomes for endoscopic sinus surgery and subsequent aspirin desensitization in aspirin-exacerbated respiratory disease
por: Lindsey Ryan, et al.
Publicado: (2020) -
Appropriate extent of surgery for aspirin-exacerbated respiratory disease
por: Ethan G. Muhonen, et al.
Publicado: (2020) -
Endogenous cannabinoids may regulate chronic inflammation in aspirin-exacerbated respiratory disease
por: Joshua M. Levy
Publicado: (2020)